KESSO-GESIC Drug Patent Profile
✉ Email this page to a colleague
When do Kesso-gesic patents expire, and when can generic versions of Kesso-gesic launch?
Kesso-gesic is a drug marketed by Mk Labs and is included in one NDA.
The generic ingredient in KESSO-GESIC is propoxyphene hydrochloride. There are twenty-seven drug master file entries for this compound. Additional details are available on the propoxyphene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KESSO-GESIC?
- What are the global sales for KESSO-GESIC?
- What is Average Wholesale Price for KESSO-GESIC?
Summary for KESSO-GESIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 2,149 |
| DailyMed Link: | KESSO-GESIC at DailyMed |
US Patents and Regulatory Information for KESSO-GESIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mk Labs | KESSO-GESIC | propoxyphene hydrochloride | CAPSULE;ORAL | 083544-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
